Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative BreastCancer.
Peter Schmid,Sylvia Adams,+16 authors, Hope S Rugo,Andreas Schneeweiss,Carlos H Barrios,Hiroji Iwata,Véronique Diéras,Roberto Hegg,Seock-Ah Im,Gail Shaw Wright,Volkmar Henschel,Luciana Molinero,Stephen Y Chui,Roel Funke,Amreen Husain,Eric P Winer,Sherene Loi,Leisha A Emens,IMpassion130 Trial Investigators. less N Engl J Med.
2018 Oct 20; 379(22):2108-2121.
PMID: 30345906
Highly Cited.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic BreastCancer.
Rashmi K Murthy,Sherene Loi,+29 authors, Alicia Okines,Elisavet Paplomata,Erika Hamilton,Sara A Hurvitz,Nancy U Lin,Virginia Borges,Vandana Abramson,Carey Anders,Philippe L Bedard,Mafalda Oliveira,Erik Jakobsen,Thomas Bachelot,Shlomit S Shachar,Volkmar Müller,Sofia Braga,Francois P Duhoux,Richard Greil,David Cameron,Lisa A Carey,Giuseppe Curigliano,Karen Gelmon,Gabriel Hortobagyi,Ian Krop,Sibylle Loibl,Mark Pegram,Dennis Slamon,M Corinna Palanca-Wessels,Luke Walker,Wentao Feng,Eric P Winer. less N Engl J Med.
2019 Dec 11; 382(7):597-609.
PMID: 31825569
Highly Cited.